openPR Logo
Press release

Intra-Uterine Contraceptive Devices Market worth 4,851.2 Million USD Globally by Top Players Analysis, Industry Growth Rate, Size, Product Type and Forecast till 2024

01-12-2018 09:46 AM CET | Health & Medicine

Press release from: Data Bridge Market Research

Intra-Uterine Contraceptive Devices Market Forecast to 2024

Intra-Uterine Contraceptive Devices Market Forecast to 2024

According to the new research report “Global Intra-Uterine Contraceptive Devices, By Product Type (Hormonal IUCD, Copper IUCD), By End-User (Hospitals, Gynecology Clinics, Community Healthcare), By Geography (North America, Europe, Asia-Pacific, South America, Rest of the World)” – Forecast to 2024

Global Intra-Uterine Contraceptive Devices Market report estimated to reach USD 4,851.2 million by 2024 from USD 3,684.1 million in 2016, at a CAGR of 3.5% in the forecast period 2017 to 2024.

Key Drivers of Global Intra-Uterine Contraceptive Devices Market:

Some of the major factors driving the market for Intra-Uterine Contraceptive Devices (IUCD), such as growing awareness of contraceptive, increased rate of unplanned pregnancies, rising number of initiatives undertaken by the private firms, technological advancements and favourable insurance for IUCD’s.

• The growing rate of unintended pregnancies has aided the increase in the adoption of contraceptive methods which is expected to drive the growth of the IUCD market.

• The rising number of initiatives to promote the use of intra uterine contraceptive devices acts as a significant driver for this market.

• Growing awareness of contraceptive one of the factors contributing to the growth of the market in Europe.

Request for Free Sample Report Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-intra-uterine-contraceptive-devices-market

Global Intra-Uterine Contraceptive Devices Industry is highly concentrated to a few big players and rest to local players who cater to domestic markets only. Bayer AG dominated the IUCD devices market accounting for a highest market share in 2016, followed by Teva Pharmaceuticals Industries Ltd., and Mona Lisa N.V. Some of the other players in this market include DKT International, Egemen International, Melbea AG, Ocon Medical Ltd., Pregna International Limited, Medical Engineering Corporation SA and, SMB Corporation and Meril Life Sciences Pvt. Ltd., Medu Scientific Ltd, China RH Contraceptives Co., Ltd, Sanghai Jolly Medical Education Co., Ltd, Bernstein Leibhard LLP, Zheijang Daji Medical Instruments, Ltd., Nimble International, AME Line, Technico, Cepeo, Contraceptivos, Injeflex Ind And Com Ltda, Bersil, Amed among others holds 34.0% of the IUCD delivery market in 2016.

BAYER HEALTHCARE AG

Founded in 1863 and headquartered in Leverkusen, Germany, Bayer AG is a provider of healthcare, nutrition, and high-technology materials and services. The company has three business segments, namely, HealthCare, Crop Science, and Material Science. The HealthCare segment offers a wide range of products under animal health, pharmaceuticals, consumer care, and medical care. The pharmaceutical business offers a wide range of products in the therapeutic area of oncology, haematology, and ophthalmology, and offers products for women’s health and cardiology therapeutic applications.

Recent Developments:

1. In October 2016, Bayer AG has successfully concluded the European registration procedure to gain EUwide marketing authorization for its new low-dose levonorgestrel-releasing intrauterine system (LNGIUS). The product is named Kyleena and will be available in the market from 2017 January.

2. In September 2016, Bayer AG has successfully received FDA approval for its new low-dose levonorgestrel releasing intrauterine system (LNG-IUS) “Kyleena” The launch of this product in October in U.S.

Inquiry for TOC Visit @ http://databridgemarketresearch.com/toc/?dbmr=global-intra-uterine-contraceptive-devices-market

TEVA PHARMACEUTICAL INDUSTRIES LTD.

Established in 1901 and headquartered in Petah Tikva, Israel, Teva is one of the leading global companies in IUCD devices market. The company is engaged in developing, producing, and marketing affordable generic drugs as well as innovative and specialty pharmaceutical ingredients. Teva operates through two business segments, namely generic medicine and specialty medicine. Teva's specialty medicines business focuses on central nervous system (CNS), respiratory oncology, pain, and women's health therapeutic areas as well as biologics.

MONA LISA N.V.:

Mona Lisa N.V. was founded in 1996, and is a subsidiary for Eurim Pharma headquarterd in Germany. Prior to 1996 the company was known as Homesteel-Achel which was an exclusive sub-manufacturer for Organon from 1980 to 1996. Mona Lisa specializes in manufacturing class II and III medical devices used in the field of gynecology. Mona Lisa N.V products are Copper-Intrauterine-Devices (IUD), Aspiration needles and Consultation services / sub-manufacturing services.

View Full Report Visit @ http://databridgemarketresearch.com/reports/global-intra-uterine-contraceptive-devices-market/

Related Report

Global Tumour Ablation Market – Trends and Forecast to 2024

Global Tumour Ablation Market, By Type (Tumour Ablation Systems (Radio Frequency Ablation, Microwave Ablation, HIFU, Laser Ablation, Cryoablation), Image Guidance Products, Accessories), By Cancer Type (Liver, Lings, Kidney, Brain, Bone, Pancreas, Breast, Others), By End-User (Hospitals, Oncology Clinics, Others), By Geography (North America, South America, Europe, Asia-Pacific, Rest of the World) – Trends and Forecast to 2024

Report Access: http://databridgemarketresearch.com/reports/global-tumour-ablation-market/

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Investor: investors@databridgemarketresearch.com
Visit Blog: http://databridgemarketresearch.com/blog/
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Intra-Uterine Contraceptive Devices Market worth 4,851.2 Million USD Globally by Top Players Analysis, Industry Growth Rate, Size, Product Type and Forecast till 2024 here

News-ID: 897429 • Views:

More Releases from Data Bridge Market Research

Tomato Ketchup Market Size to Surpass USD 19.61 billion by 2029, Share, Growth, Demand, Global Trends, Challenges and Competitive Outlook
Tomato Ketchup Market Size to Surpass USD 19.61 billion by 2029, Share, Growth, …
A crucial source of information, the Tomato Ketchup Market Research Report provides approaching and current technological and financial aspects of the industry through 2030. For the benefit of readers and end users, all gathered market data is verified and confirmed by industry professionals. With the help of this reliable marketing report, analyzing the actions of major companies and their impact on sales, import, export, revenue, and CAGR numbers becomes simple. The
Nitrile Butadiene Rubber (NBR) Market Is Projected to Value at a CAGR of 7.68%, Globally, by 2029: States Data Bridge Market Research
Nitrile Butadiene Rubber (NBR) Market Is Projected to Value at a CAGR of 7.68%, …
The top-notch Nitrile Butadiene Rubber (NBR) Market study has been created to offer a thorough examination of the market structure as well as projections for the various market segments and sub-segments. The purpose of this market study is to provide a thorough analysis of the market structure as well as a forecast for the various market segments and sub-segments. Consumer needs in the global market have been analyzed by key regions,
Professional Footwear Market to Exhibit a Noteworthy Growth by 2029, Size, Share, Growth, Demand, Drivers, Revenue Forecast and Opportunity Analysis
Professional Footwear Market to Exhibit a Noteworthy Growth by 2029, Size, Share …
Professional Footwear Market is a comprehensive and expert report that emphasizes market share, leading segments, geographic analysis, and primary and secondary drivers. A market research study includes basic, secondary, and advanced data about the state and trends of the global market as well as its size, growth, share, and segmentation as well as forecasts for the years 2023 through 2030. The study serves as the best foundation for examining competitors, evaluating
Nanoparticles Market to Observe Utmost CAGR of 6.00% by 2029, Size, Share, Demand, Key Drivers, Development Trends and Competitive Outlook
Nanoparticles Market to Observe Utmost CAGR of 6.00% by 2029, Size, Share, Deman …
The Nanoparticles Market research study offers a quantitative assessment of the primary obstacles that the company is facing both now and in the future. The main components of this market study are the market analysis, market definition, currency and price, significant advancements, and market classification in addition to a thorough research methodology. This market report's market study looks at a number of market segments that are predicted to grow at the

All 5 Releases


More Releases for Contraceptive

Contraceptive Rings Market Segmentation By product type Etonogestrel/Ethinyl est …
Contraceptive rings are smooth, flexible round shaped plastic rings which are meant to insert into vagina to on first day woman’s menstrual cycle to prevent possible pregnancy. When contraceptive rings are placed into the vagina it releases two hormones named estrogen and progestogen which are similar to natural hormones released by the body and which are also used in the contraceptive pills. Contraceptive rings release continuous dose of these hormones
Contraceptive Pills
Oral contraceptive pills is a kind of female hormonal anti-conception medication technique that is used for avoiding pregnancy. Contraceptive drugs are used to prevent the unwanted pregnancy by blocking the normal process of ovulations or by altering the process which support the fertilization of egg. The prevalence of women with unmet contraception needs was accounted at 214 million in 2018 by WHO. Further, as indicated by, United Nations,
Contraceptive Rings Market Segmentation By product type Etonogestrel/Ethinyl est …
Contraceptive rings are smooth, flexible round shaped plastic rings which are meant to insert into vagina to on first day woman’s menstrual cycle to prevent possible pregnancy. When contraceptive rings are placed into the vagina it releases two hormones named estrogen and progestogen which are similar to natural hormones released by the body and which are also used in the contraceptive pills. Contraceptive rings release continuous dose of these hormones
U.S. Contraceptives Drugs And Devices Market, By Product Type (Contraceptive Dru …
Contraceptive Drugs and Devices – Choice to Conceive, Not Concede As per stats released by Guttmacher Institute, there were around 61 million women in the U.S. in the childbearing age group (15-44 years) in 2014. Around 10% of these women do not use any contraceptive method. The UN estimates (2015) that unmet need for contraceptives in the North America region is 7%. Thus, there still is an untapped market in the
Global Contraceptives Drugs And Devices Market, By Product Type (Contraceptive D …
Contraceptives are birth spacing products that aid in avoiding unwanted/ unplanned pregnancy. There are five widely used contraceptive methods namely barrier method, hormonal method, emergency contraception, intrauterine method, and sterilization. Women can opt for wide range of contraceptive options such as vaginal rings, diaphragms, female condoms, oral pills, and intra-uterine devices (IUD). Selecting the most appropriate method is critical to avoid undesired side effects. The use of contraceptives can avoid
Oral Contraceptive Pills Market: Snapshot
Teva Pharmaceutical is one of the leading companies in the combination oral contraceptive pills segment and is followed by Allergan (Actavis) plc. Local manufacturers such as Alkem, Taj Pharma, and Zydus Alidec on the other hand, held a majority of the market for ormeloxifene and mifepristone. Transparency Market Research has observed that almost all manufacturers offer combination oral contraceptive pills owing to the fact that they are more efficient, cost